K

PriceKronos Bio

KRON

Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.

Historical stock price chart and annual return over the past years

-97%

4 years

% Total

KRON
-51%

4 years

Annual Return

KRON